Evidence map›Paper›PMID 28744400›Full record

ArticleAmerican journal of cancer research2017

Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat.

Ming-Quan Gao, Hui Gao, Mei Han, Kai-Li Liu, Jian-Jun Peng, Yan-Tao Han

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in American journal of cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ming-Quan GaoDepartment of Pharmacology, School of Pharmacy, Qingdao UniversityQingdao 266021, China.
Hui GaoDepartment of Pharmacology, School of Pharmacy, Qingdao UniversityQingdao 266021, China.
Mei HanDepartment of Pharmacology, School of Pharmacy, Qingdao UniversityQingdao 266021, China.
Kai-Li LiuDepartment of Pharmacology, School of Pharmacy, Qingdao UniversityQingdao 266021, China.
Jian-Jun PengCollege of Life Sciences, Chongqing Normal UniversityChongqing 401331, China.
Yan-Tao HanMedical College, Qingdao UniversityQingdao 266071, China.
Qingdao University · CNChongqing Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingosine 1-phosphate (S1P) rheostat is considered as a key signal that determines cell fate. This study aimed to report that hispidulin, a polyphenolic flavonoid, exerted anti-growth and anti-metastasis effects against renal cell carcinoma (RCC) by modulating the balance of ceramide-S1P.

Indexed as

Ceramidehispidulinrenal cell carcinomasphingosine 1-phosphateSphk1

Identifiers

PMID28744400
PMCPMC5523031
OpenAlexW2987565289

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.